Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2211 of 5804
-
Exercise program aims to boost quality of life in young cancer patients
Symptom relief Not yet recruitingThis project is made possible through the Pediatrics Department of the University Hospital of Salamanca, in collaboration with researchers specialized in therapeutic exercise from other clinical trials and research projects, alongside physical therapists experienced in designing,…
Phase: NA • Sponsor: University of Salamanca • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Could a food additive help fight stomach cancer? new trial explores
Disease control Not yet recruitingEligible patients were randomized into two groups: the sodium propionate group and the control group. In the control group, patients received placebo combined with anti-PD-1 therapy plus chemotherapy without additional sodium propionate intervention. In the sodium propionate grou…
Phase: NA • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Heart attack patients to receive injectable gel that may limit damage
Symptom relief Not yet recruitingThe purpose of this clinical trial is to preliminarily evaluate the safety and feasibility of the transcatheter injectable protein alginate-based hydrogel developed and manufactured by Myomed Technology (Shaoxing) Co., Ltd. in alleviating reperfusion injury in acute STEMI. This i…
Phase: NA • Sponsor: Myomed Technology (Shaoxing) Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New injection YKYY031 enters human testing for Hard-to-Treat cancers
Disease control Not yet recruitingPhase I study of YKYY031 for injection in patients with advanced solid tumors
Phase: PHASE1 • Sponsor: Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Can a virtual health educator get more native americans screened for colon cancer?
Knowledge-focused Recruiting nowThe Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS) Program addresses major regional CRC screening disparities among AI in Oklahoma. The investigators are engaged in a participatory and collaborative effort with Tribal Nations, Area …
Phase: NA • Sponsor: University of Oklahoma • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Experimental shot aims to revive weak immune systems in HIV patients
Disease control Not yet recruitingJL18008 Injection is designed to improve the immune response in cART-treated HIV-infected immunological non-responders (HIV INRs). The study includes 3 trials: Phase Ia: A randomized, single-blind, placebo-controlled, single-dose escalation study to evaluate the tolerability and …
Phase: PHASE1 • Sponsor: Jecho Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Exercise program aims to keep heart transplant patients strong while they wait
Symptom relief Not yet recruitingHeart failure is a condition where the heart cannot pump blood effectively. This can happen due to changes in the heart's structure or function, leading to symptoms like shortness of breath, fatigue, and reduced ability to exercise. These symptoms often worsen the patient's quali…
Phase: NA • Sponsor: University of Nove de Julho • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Texting teens to breathe easier: new asthma adherence trial
Disease control Not yet recruitingThe primary objective is to examine the efficacy of an mHealth adherence intervention (Asthma Ctrl) on adherence to daily inhaled corticosteroids as measured by electronically monitored adherence in adolescents with asthma. The secondary objective is to compare the effectiveness …
Phase: NA • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Herbal hope: new capsule aims to ease Opioid-Induced constipation in cancer patients
Symptom relief Not yet recruitingThis study intends to design and conduct a prospective, multicenter, randomized, parallel-controlled, superiority trial to evaluate the symptom-relieving effects of Shouhui Tongbian Capsule on opioid-induced constipation (OIC) in cancer patients, including defecation frequency, s…
Phase: PHASE3 • Sponsor: First Teaching Hospital of Tianjin University of Traditional Chinese Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Can acupuncture spark awareness in Brain-Injury patients?
Symptom relief Not yet recruitingDisorder of consciousness (DOC) is a common complication of severe central nervous system injury. It is defined as prolonged DOC when lasting more than 28 days. About 300,000-800,000 patients are affected worldwide, with an annual mortality rate of 29%-50%, causing a heavy social…
Phase: NA • Sponsor: The Third People's Hospital of Huizhou • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
New drug cocktail aims to tackle tough lymphoma
Disease control Not yet recruitingThis is a multicenter, open-label phase Ib study, evaluating the safety, tolerability, preliminary efficacy and PK characteristics of Rocbrutinib (LP-168) combined with R-GemOx in patients with R/R non-GCB DLBCL. Study includes dose escalation part and dose expansion part. In the…
Phase: PHASE1 • Sponsor: Guangzhou Lupeng Pharmaceutical Company LTD. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New Dual-Targeting antibody enters human trials for Hard-to-Treat cancers
Disease control Not yet recruitingThis is an open-label, multicenter Phase I study designed to evaluate the safety, tolerability, pharmacokinetic characteristics, and preliminary antitumor activity of JH021 injection in patients with advanced solid tumors. JH021 is a bispecific monoclonal antibody targeting EGFR …
Phase: PHASE1 • Sponsor: Biotech Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Ultrasound showdown: which test best spots returning liver cancer?
Diagnosis Not yet recruitingHepatocellular carcinoma (HCC) is the sixth most common malignant tumor worldwide, with a significantly increased incidence among patients with liver diseases. Even if HCC can be treated by surgical resection and ablation, the 5-year recurrence rate is as high as 50-70%. The Live…
Sponsor: The First Hospital of Jilin University • Aim: Diagnosis
Last updated Jun 27, 2026 12:36 UTC
-
AI eye scan predicts treatment shifts for diabetic macular edema
Knowledge-focused Not yet recruitingThis study is to assess the use of Artificial intellignce (AI) to predict eye treatment changes in adult participants with diabetic macular edema (DME).
Sponsor: AbbVie • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
AI nudge aims to boost colon cancer screening in china
Prevention Not yet recruitingColorectal cancer (CRC) ranks third in both incidence and mortality among all malignant tumors in China. Studies have shown that early screening can significantly reduce its incidence and mortality. Colonoscopy is the gold standard for CRC screening; however, compliance with colo…
Phase: NA • Sponsor: Fudan University • Aim: Prevention
Last updated Jun 27, 2026 13:03 UTC
-
New heart scan could speed up amyloidosis diagnosis
Diagnosis Not yet recruitingTransthyretin cardiac amyloidosis (ATTR-CA) is traditionally diagnosed using planar bone scintigraphy with a Perugini visual score ≥ 2. Fast cardiac CZT-SPECT will be evaluated for its ability to reproduce this classification and provide reproducible quantitative myocardial uptak…
Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC
-
New online support programme aims to ease burden on heart failure carers
Symptom relief Recruiting nowBackground: Heart failure (HF) is widespread in the United Kingdom (UK). Many of these patients rely on support from family carers who are ill-prepared and supported for this role. These carers often experience poor mental and physical health because of their caring role. HEart …
Phase: NA • Sponsor: Queen's University, Belfast • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Eczema flare predictor device tested in new study
Knowledge-focused Recruiting nowThis study will collect skin measurements from people with atopic dermatitis (AD) using the investigational Nevisense Go device. Participants aged 12 to 89 years with a history of AD flares will use the device at home for about 90 days. Participants will complete device measureme…
Sponsor: Castle Biosciences Incorporated • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Can a common arthritis drug make PKU treatment safer and more effective?
Disease control Recruiting nowStudy 165-401 is a Phase 4, open-label study designed to examine the concomitant use of methotrexate (MTX) to suppress immune responses to Palynziq and improve tolerability and efficacy in adults with PKU.
Phase: PHASE4 • Sponsor: BioMarin Pharmaceutical • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo aims to boost CAR-T safety in lymphoma patients
Disease control Recruiting nowThis clinical trial assesses whether it is feasible to use radiation therapy with vancomycin prior to CAR T-cell therapy for patients with large B-cell lymphomas
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC